This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.
BC PharmaCare has issued a call for Patient Input into whether they should cover AbbVie’s new hepatitis C treatment, HOLKIRA PAK™ (ombitasvir, paritaprevir, ritonavir, and dasabuvir [±ribavirin]).
HepCBC is going to make a submission to BC PharmaCare, and URGENTLY requests input from those who have, or have ever had hepatitis C (and their caregivers). Our submission is only as good as the input we get from people like you!
You would have to answer a few questions and email us the answers by MIDNIGHT on SUNDAY, MAY 17th. Thanks so much! (Be sure to look over the Background Information below if you are unfamiliar with how this treatment compares to others).
BACKGROUND INFORMATION ABOUT HOLKIRA PAK™:
http://hepcbc.bchep.org/holkira-pak-background-info/
HOW TO SUBMIT YOUR INPUT; CLICK HERE:
http://hepcbc.bchep.org/questions-bc-pharmacare-holkira-pak/